Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.
about
A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.Kawasaki disease and coronary artery aneurysms: from childhood to adulthood.Dissecting Kawasaki disease: a state-of-the-art review.Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.Long-Term Outcome of Kawasaki Disease Complicated by a Large Coronary Aneurysm.Safety netting versus overtreatment in paediatrics: viral infection or incomplete Kawasaki disease?A comparative study of established z score models for coronary artery diameters in 181 healthy Korean children.One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.Myocardial Perfusion Reserve Index in Children With Kawasaki Disease.Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.Treatment Options for Resistant Kawasaki Disease.Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.Recovery of myocardial mechanics in Kawasaki disease demonstrated by speckle tracking and tissue Doppler methods.Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial.Diagnosis of Kawasaki disease.Controversies in diagnosis and management of Kawasaki disease.The role of echocardiography in Kawasaki disease.miR‑186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease.Clinical assessment of coronary arteries in Kawasaki disease: Focus on echocardiographic assessment.Role of intravenous immunoglobulin in the treatment of Kawasaki disease.Kawasaki disease - the journey over 50 years: 1967-2017.Study design and rationale to assess Doxycycline Efficacy in preventing coronary Artery Lesions in children with Kawasaki disease (DEAL trial) - A phase II clinical trial.Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution.Role of glucocorticoids in Kawasaki disease.Computational blood flow simulations in Kawasaki disease patients: Insight into coronary artery aneurysm hemodynamics.Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.Acute Kawasaki disease with emphasis on the echocardiographic profile: A single center experience.Pseudo-normalization of a coronary artery aneurysm detected by IVUS.Incomplete Kawasaki disease in Egypt.Kawasaki disease: multiple giant coronary aneurysms intervention and pacemaker implantation due to complete heart block-a case report.The emergence of Kawasaki disease in India and China.Giant coronary artery aneurysms in a 12-week-old infant with incomplete Kawasaki disease.Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease.Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection.Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease.Laboratory Biomarkers to Facilitate Differential Diagnosis between Measles and Kawasaki Disease in a Pediatric Emergency Room: A Retrospective Study.Frequently asked questions regarding treatment of Kawasaki disease.Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide.A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease.Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment.
P2860
Q38601519-A9544FB2-CE88-41FE-8D2E-6D98EEF40736Q38638912-1E3BD3CD-5407-4953-A4EE-16E0FB5900B1Q39401720-D0A41101-06E8-4B71-9010-220698D191AEQ40134948-5559FFCF-D25E-4AAE-B0F7-E917E1AB3CF6Q42340372-4C38A8C6-F5A7-4F22-94DE-9A351CE07E2BQ47104522-19B4B21B-CB47-460B-9A58-E537DDA71F61Q47155437-1B859CBB-00B5-4FB0-BC0F-91F2C9D5F88DQ47182586-3CEC069F-51C3-456F-BC8B-441772A835F9Q47258165-81391416-6594-4814-A093-46F3D9272509Q47589960-9EFB4ED5-F9C4-4372-AAEB-3B2E9C75C239Q47660588-CFF25896-4E7D-4733-BDFE-46BB7820B5ADQ47846103-E1646953-4740-4967-91FC-2A1A9476B01FQ48120209-D43F4C2A-8651-45F0-B0D6-D346C26398FBQ48130791-B808F582-FBB3-4C4E-91FF-AFFF4A25A577Q48315964-855CC1F8-3487-4986-B0EB-C2DB08E6C621Q49873428-07C0430C-2B5C-412D-AC5C-5C0484373574Q49891799-D4802589-AC8C-46CF-9FE3-5970A83A0E08Q49981880-4E96B012-11F9-4EC9-8860-291C3CEB7630Q50044847-9744E56C-ED48-41BC-9506-FF8E709AC3D6Q50071875-EA67BC70-009B-402A-93AA-C2514D97C746Q50113369-6E2BD45D-710F-426F-90F5-B5B67B01F6A8Q50125883-8C942938-E787-45DA-BDDA-E245D5454FECQ50133401-ABC80B54-894E-48AB-85A4-BEB042464F39Q50144746-A6919C12-8D0C-4223-8269-479D84CE2183Q51556557-E65641C9-190C-4A46-AD09-79069F73E9B5Q51735974-EDA65D99-5D42-4F60-B7E7-EA0B2C9086D8Q52643449-F0A3B969-88AA-4900-9608-BFD9D4614D94Q53699539-D7D68B2E-1EF1-4150-B0CA-9B73DBE8F86FQ53699549-C63C6349-5FEE-4D42-85AF-1EDC94A42EAAQ53833330-FBBDBEEF-5738-42E1-9173-05757B27887EQ54155405-00D96255-494D-4B0F-8C5C-CFE8C78FC625Q54246635-085F0354-1EC9-492D-BBFE-0D7110EA9488Q54248487-906EB80F-6F12-4AAC-A837-AF8114316636Q54251263-5C4EBF04-643D-4FF7-B228-207253053155Q55002256-B47791AF-82A5-4922-B419-F3DF8B720518Q55003238-9540864B-01BF-4F1A-857F-50C46484A229Q55009948-66B64CCF-2FCF-4CAC-B442-B1DA2449B5ECQ55035955-992B5F43-9E4A-43E1-9B2D-5A6BF66B3821Q55057339-12DDF56F-351B-440F-A63B-B92550BEC4BBQ55108848-D559ED08-F141-48F4-975A-E8E810132E0E
P2860
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Diagnosis, Treatment, and Long ...... he American Heart Association.
@ast
Diagnosis, Treatment, and Long ...... he American Heart Association.
@en
type
label
Diagnosis, Treatment, and Long ...... he American Heart Association.
@ast
Diagnosis, Treatment, and Long ...... he American Heart Association.
@en
prefLabel
Diagnosis, Treatment, and Long ...... he American Heart Association.
@ast
Diagnosis, Treatment, and Long ...... he American Heart Association.
@en
P2093
P1433
P1476
Diagnosis, Treatment, and Long ...... he American Heart Association.
@en
P2093
American Heart Association Rhe ...... on Epidemiology and Prevention
Anne F Bolger
Anne H Rowley
Annette L Baker
Brian W McCrindle
Elfriede Pahl
Jane C Burns
Mary Anne Jackson
Masato Takahashi
Mei-Hwan Wu
P304
P356
10.1161/CIR.0000000000000484
P407
P577
2017-03-29T00:00:00Z